Skip to main content
    B

    BioRestorative Therapies Inc (BRTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.42
    -0.07 (-4.70%)

    Market Cap: $2.06M

    Last updated: Nov 17, 2026 at 11:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    65%(13/20)
    Avg Surprise
    -4.81%

    Upcoming Estimates

    Reports Mar 24, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$2.04
    Range-$2.55 - -$1.47
    4 analysts
    Revenue Consensus
    $395.25K
    Range$98.00K - $708.75K
    4 analysts

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin-3975.00%
    ROE-241.10%ROIC-289.87%
    Financial Health
    Debt/Equity0.01xInterest Coverage67.54x
    Current Ratio2.35xQuick Ratio2.35x
    Trading Statistics
    Beta0.84Avg Volume26.16K
    52-Week High$2.9352-Week Low$0.14

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 28.0% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 35.7, in the neutral range between 30 and 70.

    Moving Averages

    SMA 10$1.51
    SMA 20$1.51
    SMA 50$1.97
    SMA 200$5.12
    EMA 10$1.50
    EMA 20$1.58
    EMA 50$2.17
    EMA 200$7.25

    MACD

    Line: -0.15Signal: -0.20Hist: 0.05

    ADX

    ADX: 16.6+DI: 9.9-DI: 11.7

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down12.0
    PSAR$2.53

    Bollinger Bands

    Upper Band$1.65
    Lower Band$1.36
    %B Position1878%(Upper)
    Band Width0.20

    RSI (14-Day)

    Neutral
    35.7

    Momentum Oscillators

    Stoch %K37.0
    Stoch %D49.9
    Williams %R-82.1
    ROC (10d)-4.1%
    Momentum-0.06
    CCI (20d)-127.1
    MFI (14d)82.3

    Volatility Measures

    ATR (14d)$0.25(17.5%)
    StdDev (20d)0.07
    Hist Vol97.8%(High)

    Volume Flow

    VWAP$1.44
    OBV874.8M
    AD Line193.3B
    CMF (20d)0.131

    Volume Metrics

    Avg Vol (20d)26.5K
    Vol Ratio0.5x(Low)
    VWMA (20d)$1.54

    Pivot Points

    R3$1.66
    R2$1.61
    R1$1.55
    Pivot Point$1.50
    S1$1.44
    S2$1.39
    S3$1.33

    Advanced Oscillators

    TSI-27.20
    Ultimate Osc39.1
    KST-199.30

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about BRTX

    News

    BRTX Valuation

    BRTX Profitability: Margins, ROIC and FCF

    BioRestorative Therapies (BRTX) has a gross margin of 92.1%, an operating margin of -3975.0% and a net margin of 0.0%. It posts -289.9% ROIC and a -3324.6% FCF margin.

    Gross margin
    92.1%
    Operating margin
    -3975.0%
    Net margin
    0.0%
    ROIC
    -289.9%
    ROE
    -241.1%
    FCF margin
    -3324.6%
    BRTX financial statements

    BioRestorative Therapies Competitors

    The companies most similar to BioRestorative Therapies (BRTX) include Revelation Biosciences, Bone Biologics and Ernexa Therapeutics.

    Sector: Healthcare

    Companies most similar to BioRestorative Therapies

    BRTX Bull Case vs Bear Case

    Bull case

    • BRTX beat EPS estimates in 75.0% of its last 8 reported quarters.

    Bear case

    • BRTX's quarterly revenue changed -7.3% year over year.

    BRTX Earnings: Beat Rate and Next Report

    BioRestorative Therapies (BRTX) beat the EPS estimate in 6 of the last 8 quarters (75.0%). Its next report is expected on Mar 24, 2027.

    Beat rate
    6 of 8 quarters (75.0%)
    Average surprise
    -6.8%
    EPS estimate (fiscal period ending Dec 31, 2026)
    -$2.04
    BRTX earnings history

    BRTX Earnings Date

    BRTX reports Mar 24, 2027. The date is estimated.

    BRTX Earnings Call

    The latest BRTX earnings call transcript on file is labeled 2025Q3.

    Read the 2025Q3 transcript

    BRTX ETF Holders

    Updated Nov 11, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About BRTX

    When does BRTX report earnings?

    BioRestorative Therapies Inc (BRTX) is expected to report earnings on Mar 24, 2027.

    Does BRTX pay dividends?

    BioRestorative Therapies Inc (BRTX) does not currently pay a regular dividend.

    What is BRTX's market cap?

    BioRestorative Therapies Inc (BRTX) has a market capitalization of $2.06M with a current stock price of $1.42.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.